Holdings of Trails Edge Capital Partners, LP
22 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 70.3 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 95.8 %
- FR 4.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 21 | 337.9M $ | 95.82 % |
| 2 | FR | 1 | 14.8M $ | 4.18 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Vaxcyte Inc | 662,470 | 38.5M $ | |
| 2 | LB Pharmaceuticals Inc | 1,319,362 | 32.5M $ | |
| 3 | Mirum Pharmaceuticals Inc | 333,312 | 30.8M $ | |
| 4 | Nurix Therapeutics Inc | 1,743,220 | 27M $ | |
| 5 | Revolution Medicines Inc | 245,000 | 23.8M $ | |
| 6 | Arcus Biosciences Inc | 1,047,935 | 22.6M $ | |
| 7 | Immunocore Holdings PLC | 682,597 | 20.6M $ | |
| 8 | Cytokinetics Inc | 300,000 | 19.8M $ | |
| 9 | Syndax Pharmaceuticals Inc | 701,821 | 16.4M $ | |
| 10 | Neurogene Inc | 782,787 | 15.8M $ | |
| 11 | Inventiva SACA | 2,657,997 | 14.8M $ | |
| 12 | Inhibikase Therapeutics Inc | 8,057,345 | 13.5M $ | |
| 13 | 4D Molecular Therapeutics Inc | 1,302,917 | 12.1M $ | |
| 14 | X4 PHARMACEUTICALS INC | 2,571,478 | 10.6M $ | |
| 15 | Immunovant Inc | 414,054 | 10.3M $ | |
| 16 | Design Therapeutics Inc | 852,013 | 9.1M $ | |
| 17 | CAMP4 THERAPEUTICS CORP | 1,939,563 | 8.6M $ | |
| 18 | Minerva Neurosciences Inc | 1,419,000 | 8.5M $ | |
| 19 | Century Therapeutics Inc | 2,449,993 | 5.5M $ | |
| 20 | VTV THERAPEUTICS INC | 139,578 | 5.5M $ | |
| 21 | SENSEI BIOTHERAPEUTICS INC | 125,000 | 3.9M $ | |
| 22 | Opus Genetics Inc | 500,000 | 2.3M $ |